Tampere University Hospital, Department of Urology
Welcome,         Profile    Billing    Logout  
 12 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tammela, Teuvo L
NCT03139734: Sacral Neuromodulation for Pelvic Pain Associated With Endometriosis

Recruiting
N/A
50
Europe
Sacral Neuromodulation, Sacral Nerve Stimulation, Sacral Nerve Modulation
Seinajoki Central Hospital, Helsinki University Central Hospital, Turku University Hospital, Tampere University Hospital, Oulu University Hospital, Jyväskylä Central Hospital
Endometriosis
05/22
05/22
SPCG-15, NCT02102477: Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

Recruiting
N/A
1200
Europe
Prostatectomy/Surgery, Radiotherapy with adjuvant androgen deprivation therapy
Olof Akre
Prostatic Neoplasms
12/25
12/45
Murtola, Teemu J
ESTO2, NCT04026230: Impact of Atorvastatin on Prostate Cancer Progression During ADT

Recruiting
3
400
Europe
Atorvastatin 80mg, Lipitor, Placebo oral capsule
Tampere University Hospital, Turku University Hospital, Central Finland Hospital District, Tartu University Hospital, University of Aarhus, Fimlab laboratories, Helsinki University Central Hospital, Kuopio University Hospital, Oulu University Hospital, Seinajoki Central Hospital, The Hospital of Vestfold, Telemark Hospital Trust
Metastatic Prostate Cancer, Recurrent Prostate Cancer
12/25
12/25
MOVES, NCT05796973: Measuring Oncological Value of Exercise and Statin

Recruiting
3
240
Europe
Guided physical exercise, Atorvastatin, Independent exercise
Tampere University Hospital, Tampere University, Aalto University, University of Helsinki, University of Turku
Prostate Cancer, Breast Cancer, Kidney Cancer, Ovarian Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Metastatic Prostate Cancer, Metastatic Prostate Adenocarcinoma, Metastatic Ovarian Cancer, Metastatic Ovary Cancer
12/25
12/27
GrandP/SPCG19, NCT05448547: Immediate Curative Vs Conservative Treatment in Older Men with M0, High-risk Prostate Cancer

Recruiting
3
980
Europe
Radiotherapy or surgery, initial observation, Hormone therapy
Sven Löffeler, Oslo University Hospital, Klinbeforsk
Prostate Cancer
12/29
12/36
TASTEPRO, NCT05067660: Targeted Radiotherapy for Recurrent Prostate Cancer

Not yet recruiting
N/A
40
Europe
Stereotactic ablative radiotherapy, Current standard template-based salvage therapy
Tampere University Hospital, Tampere University
Prostate Cancer Recurrence After Radical Prostatectomy
12/23
01/25
SPCG-15, NCT02102477: Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

Recruiting
N/A
1200
Europe
Prostatectomy/Surgery, Radiotherapy with adjuvant androgen deprivation therapy
Olof Akre
Prostatic Neoplasms
12/25
12/45
PCASTT, NCT02914873: SPCG17: Prostate Cancer Active Surveillance Trigger Trial

Active, not recruiting
N/A
2000
Europe
Active surveillance
Uppsala University
Prostate Cancer
12/34
12/34
Kaipia, Antti
NCT03550040: 3D Versus Robot Assisted Laparoscopic Prostatectomy.

Terminated
N/A
155
Europe
Radical prostatectomy, Total prostatectomy
Tampere University Hospital, Seinajoki Central Hospital
Prostate Cancer
07/21
07/22
multi-IMRPOD2, NCT04287088: bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis

Recruiting
N/A
600
Europe
A shared decision making
Turku University Hospital, Tampere University Hospital, Satakunta Central Hospital, Central Finland Hospital District, Memorial Sloan Kettering Cancer Center, Mount Sinai Hospital, New York
Prostate Cancer
12/21
12/41
Koskimäki, Juha
NCT01675219 / 2012-000559-15: Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

Active, not recruiting
3
400
Europe
white light TUR-BT, blue light TUR-BT, optimized MMC, optimized mitomycin-C, single immediate chemotherapy instillation, single instillation
Turku University Hospital, Finnbladder
Bladder Cancer
12/21
08/23

Download Options